Uporedite metode
Pregledajte izabrane metode jednu pored druge; redovi koji se razlikuju su istaknuti.
| Analiza prekinutih vremenskih serija (ITS)× | Uskladiivanje rezultata sklonosti× | |
|---|---|---|
| Oblast≠ | Kauzalno zaključivanje | Istraživačka statistika |
| Porodica≠ | Regression model | Process / pipeline |
| Godina nastanka≠ | 2002 | 1983 |
| Tvorac≠ | Wagner, Soumerai, Zhang & Ross-Degnan (segmented regression); Bernal, Cummins & Gasparrini (tutorial) | Paul Rosenbaum and Donald Rubin |
| Tip≠ | Quasi-experimental segmented regression | Method |
| Temeljni izvor≠ | Bernal, J. L., Cummins, S., & Gasparrini, A. (2017). Interrupted time series regression for the evaluation of public health interventions: a tutorial. International Journal of Epidemiology, 46(1), 348-355. DOI ↗ | Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. DOI ↗ |
| Drugi nazivi | ITS analysis, segmented regression of time series, Kesintili Zaman Serisi (ITS) Analizi | PSM, propensity score weighting, covariate balance |
| Srodne≠ | 5 | 3 |
| Sažetak≠ | Interrupted Time Series analysis is a quasi-experimental design that estimates the effect of a single, well-dated intervention by comparing the trajectory of an outcome before and after it occurs. Formalised as segmented regression by Wagner and colleagues (2002) and popularised as a public-health evaluation tutorial by Bernal, Cummins and Gasparrini (2017), it separates the intervention's impact into a change in level and a change in slope. | Propensity score matching (PSM) is a method for reducing confounding bias in observational studies by balancing baseline characteristics between treatment groups, simulating randomization. Developed by Rosenbaum and Rubin (1983), it estimates the probability of receiving treatment given observed covariates, then matches or weights treated and control individuals with similar treatment probabilities. Widely used in medicine, epidemiology, and policy evaluation when randomized trials are infeasible or unethical, enabling estimation of treatment effects while controlling for selection bias. |
| ScholarGateSkup podataka ↗ |
|
|